Scholar Rock Holding Corporation (SRRK) Fundamentals

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States. The company's lead product candidate is SRK-015 which is a highly selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle.
SHARE INFORMATION
Market Cap$ 501,947,118
Shares Outstanding51,640,650
Float34,708,842
Percent Float67.21%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 18,816,000
Latest Fiscal EPS$ -3.59
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions284
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months6,300,664
Institutional Holdings Percent101.8%
Institutional Sold Previous 3 Months7,967,500
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months2,275,949
Insider Holdings Percent8.6
Insider Sold Previous 3 Months37,459
Insider Shares Owned4,427,753
TRADING INFO
52 Week High$ 44.95
52 Week Low$ 4.33
52 Week High Change$ -75.01
21 Day Moving Average$ 8.3543
21 Day Extended Moving Average$ 8.67
50 Day Moving Average$ 7.1518
50 Day Extended Moving Average$ 7.9569
200 Day Moving Average$ 14.8708
200 Day Extended Moving Average$ 14.1288
10 Day Average Volume534,894
20 Day Average Volume467,037
30 Day Average Volume592,693
50 Day Average Volume1,533,287
Alpha0.007625
Beta0.6297
Standard Deviation0.278137
R20.014737
7 Day Price Change$ 0.63
7 Day Percent Change6.93%
21 Day Price Change$ 2.35
21 Day Percent Change31.89%
30 Day Price Change$ 1.74
30 Day Percent Change21.8%
Month to Date Price Change$ 2.86
Month to Date Percent Change41.69%
Quarter to Date Price Change$ 4.23
Quarter to Date Percent Change77.05%
180 Day Price Change$ -8.16
180 Day Percent Change-45.64%
200 Day Price Change$ -6.92
200 Day Percent Change-41.59%
Year to Date Price Change$ -15.12
Year to Date Percent Change-60.87%

Scholar Rock Holding Corporation (SRRK) Key Ratios

PROFITABILITY
EBIT Margin-286.9%
EBITDA Margin-280.1%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 42,706,000
Revenue Per Share$ 0.827
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.80
Total Debt To Equity0.20
Int Coverage0.00
Current Ratio9.70
Leverage Ratio1.50
Quick Ratio9.20
Long Term Debt To Capital0.14
VALUATION MEASURES
PE Ratio-3.50
Enterprise Value$ 286,210,938
Price to Sales11.7536
Price to Free Cash-3.90
PE High Last 5 Years0.00
Price To Book1.80
Price To Cash Flow46.20
PE Low Last 5 Years0.00
Price to Tangible Book1.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.30
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-34.94
Return on Equity-48.13
Return on Capital-37.12

Scholar Rock Holding Corporation (SRRK) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEONagesh K. Mahanthappa
Emplyoees145
Last AuditUQ
CIK0001727196
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address301 Binney Street
3rd Floor
Cambridge, MA 2142
Websitehttps://www.scholarrock.com
Facsimile+1 866 493-4935
Telephone+1 857 259-3860
Emailchu@scholarrock.com


Your Recent History
NASDAQ
SRRK
Scholar Ro..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.